Is it time for anti-CD20 discontinuation in multiple sclerosis? Cumulative risk or cumulative uncertainty. Zanghì A, Van Der Walt A, D'Amico E Front Immunol. 2026; 17:1917676. PMID: 42991313. Abstract CommentRecommendBookmarkWatch